Department of Medicine
Stephen J. Clarke has not added Biography.
If you are Stephen J. Clarke and would like to personalize this page please email our Author Liaison for assistance.
Life-threatening anaphylactoid reaction to amifostine used with concurrent chemoradiotherapy for nasopharyngeal cancer in a patient with dermatomyositis: a case report with literature review.
Anti-cancer drugs Mar, 2002 | Pubmed ID: 11984077
Use of the Internet by oncology patients: its effect on the doctor-patient relationship.
The Medical journal of Australia Oct, 2002 | Pubmed ID: 12358586
Pemetrexed: single-agent and combination phase I study overview.
Seminars in oncology Dec, 2002 | Pubmed ID: 12571806
Inflammatory response: an unrecognised source of variability in the pharmacokinetics and pharmacodynamics of cancer chemotherapy.
The lancet oncology Apr, 2003 | Pubmed ID: 12681266
Thymidylate synthase inhibitors.
Cancer chemotherapy and biological response modifiers , 2002 | Pubmed ID: 12703198
Population pharmacokinetics of weekly docetaxel in patients with advanced cancer.
British journal of clinical pharmacology Jan, 2004 | Pubmed ID: 14678339
Baseline nutritional assessment in advanced cancer patients receiving palliative chemotherapy.
Nutrition and cancer , 2003 | Pubmed ID: 14690790
Population pharmacokinetics of raltitrexed in patients with advanced solid tumours.
British journal of clinical pharmacology Apr, 2004 | Pubmed ID: 15025739
Factors affecting cytochrome P-450 3A activity in cancer patients.
Clinical cancer research : an official journal of the American Association for Cancer Research Dec, 2004 | Pubmed ID: 15623611
Management of chemotherapy-induced nausea, vomiting, oral mucositis, and diarrhoea.
The lancet oncology Feb, 2005 | Pubmed ID: 15683818
A phase I/II study of pemetrexed and vinorelbine in patients with non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) Sep, 2005 | Pubmed ID: 15923057
Nutritional assessment in cancer: comparing the Mini-Nutritional Assessment (MNA) with the scored Patient-Generated Subjective Global Assessment (PGSGA).
Nutrition and cancer , 2005 | Pubmed ID: 16351506
Predicting the toxicity of weekly docetaxel in advanced cancer.
Clinical pharmacokinetics , 2006 | Pubmed ID: 16719542
Advances in the adjuvant treatment of colorectal cancer.
ANZ journal of surgery May, 2006 | Pubmed ID: 16768699
Altered deoxyuridine and thymidine in plasma following capecitabine treatment in colorectal cancer patients.
British journal of clinical pharmacology Jan, 2007 | Pubmed ID: 16827816
Relationship of hepatic functional imaging to irinotecan pharmacokinetics and genetic parameters of drug elimination.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology Sep, 2006 | Pubmed ID: 16896007
Evaluation of nutritional and inflammatory status of advanced colorectal cancer patients and its correlation with survival.
Nutrition and cancer , 2006 | Pubmed ID: 16965244
Nutrition intervention using an eicosapentaenoic acid (EPA)-containing supplement in patients with advanced colorectal cancer. Effects on nutritional and inflammatory status: a phase II trial.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer Mar, 2007 | Pubmed ID: 17021855
Transcriptional repression of hepatic cytochrome P450 3A4 gene in the presence of cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research Dec, 2006 | Pubmed ID: 17189422
Prognostic factors predictive of response and survival to a modified FOLFOX regimen: importance of an increased neutrophil count.
Clinical colorectal cancer Nov, 2006 | Pubmed ID: 17241514
Regulation of drug-metabolizing enzymes and transporters in infection, inflammation, and cancer.
Drug metabolism and disposition: the biological fate of chemicals Feb, 2008 | Pubmed ID: 18218849
Thymidylate synthase and methylenetetrahydrofolate reductase gene polymorphisms and toxicity to capecitabine in advanced colorectal cancer patients.
Clinical cancer research : an official journal of the American Association for Cancer Research Feb, 2008 | Pubmed ID: 18245544
Inflammation and CYP3A4-mediated drug metabolism in advanced cancer: impact and implications for chemotherapeutic drug dosing.
Expert opinion on drug metabolism & toxicology Feb, 2008 | Pubmed ID: 18248309
Potential regional differences for the tolerability profiles of fluoropyrimidines.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology May, 2008 | Pubmed ID: 18445840
Systemic inflammatory response predicts prognosis in patients with advanced-stage colorectal cancer.
Clinical colorectal cancer Sep, 2008 | Pubmed ID: 18794066
Ethnic differences in drug metabolism and toxicity from chemotherapy.
Expert opinion on drug metabolism & toxicology Mar, 2009 | Pubmed ID: 19331590
Eligibility of patients with advanced non-small cell lung cancer for phase III chemotherapy trials.
BMC cancer , 2009 | Pubmed ID: 19402889
Inflammatory (B) symptoms are independent predictors of myelosuppression from chemotherapy in Non-Hodgkin Lymphoma (NHL) patients--analysis of data from a British National Lymphoma Investigation phase III trial comparing CHOP to PMitCEBO.
BMC cancer , 2009 | Pubmed ID: 19450285
A novel approach to investigate the subcellular distribution of nuclear receptors in vivo.
Nuclear receptor signaling , 2009 | Pubmed ID: 19471583
The alternatively spliced murine pregnane X receptor isoform, mPXR(delta171-211) exhibits a repressive action.
The international journal of biochemistry & cell biology May, 2010 | Pubmed ID: 20060928
Predictive biomarkers of clinical response to targeted antibodies in colorectal cancer.
Current opinion in molecular therapeutics Dec, 2009 | Pubmed ID: 20072938
Surface antigen profiling of colorectal cancer using antibody microarrays with fluorescence multiplexing.
Journal of immunological methods Apr, 2010 | Pubmed ID: 20156443
Liver membrane proteome glycosylation changes in mice bearing an extra-hepatic tumor.
Molecular & cellular proteomics : MCP Sep, 2011 | Pubmed ID: 20167946
Clinicopathological correlates and prognostic significance of maspin expression in 450 patients after potentially curative resection of node-positive colonic cancer.
Histopathology Feb, 2010 | Pubmed ID: 20459532
Clinical, laboratory and molecular factors predicting chemotherapy efficacy and toxicity in colorectal cancer.
Critical reviews in oncology/hematology Sep, 2011 | Pubmed ID: 20719530
Clinical trial information as a measure of quality cancer care.
Journal of oncology practice / American Society of Clinical Oncology May, 2010 | Pubmed ID: 20808563
Patient and oncologist estimates of survival in advanced cancer patients.
Psycho-oncology Feb, 2011 | Pubmed ID: 20878829
Taking less than prescribed: medication nonadherence and provider-patient relationships in lower-income, rural minority adults with hypertension.
Journal of clinical hypertension (Greenwich, Conn.) Sep, 2010 | Pubmed ID: 20883231
High blood neutrophil-to-lymphocyte ratio is an indicator of poor prognosis in malignant mesothelioma patients undergoing systemic therapy.
Clinical cancer research : an official journal of the American Association for Cancer Research Dec, 2010 | Pubmed ID: 20956618
The development of multiple reaction monitoring assays for liver-derived plasma proteins.
Proteomics. Clinical applications Dec, 2007 | Pubmed ID: 21136656
Reporting clinical trial information: colorectal cancer trials at Sydney Cancer Centre.
Internal medicine journal Feb, 2011 | Pubmed ID: 21299781
Pharmacometabonomic profiling as a predictor of toxicity in patients with inoperable colorectal cancer treated with capecitabine.
Clinical cancer research : an official journal of the American Association for Cancer Research May, 2011 | Pubmed ID: 21415219
Supporting treatment decision making in advanced cancer: a randomized trial of a decision aid for patients with advanced colorectal cancer considering chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology May, 2011 | Pubmed ID: 21483008
Extrahepatic cancer suppresses nuclear receptor-regulated drug metabolism.
Clinical cancer research : an official journal of the American Association for Cancer Research May, 2011 | Pubmed ID: 21498392
Single-agent irinotecan or 5-fluorouracil and leucovorin (FOLFIRI) as second-line chemotherapy for advanced colorectal cancer; results of a randomised phase II study (DaVINCI) and meta-analysis.
European journal of cancer (Oxford, England : 1990) Aug, 2011 | Pubmed ID: 21665462
Effect of medical Qigong on cognitive function, quality of life, and a biomarker of inflammation in cancer patients: a randomized controlled trial.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer Jun, 2011 | Pubmed ID: 21688163
Medication adherence among rural, low-income hypertensive adults: a randomized trial of a multimedia community-based intervention.
American journal of health promotion : AJHP Jul-Aug, 2011 | Pubmed ID: 21721962
Proteomic comparison of colorectal tumours and non-neoplastic mucosa from paired patient samples using iTRAQ mass spectrometry.
Molecular bioSystems Nov, 2011 | Pubmed ID: 21808808
Clinical pharmacology of chemotherapy agents in older people with cancer.
Current gerontology and geriatrics research , 2011 | Pubmed ID: 21845189
An update on ethnic differences in drug metabolism and toxicity from anti-cancer drugs.
Expert opinion on drug metabolism & toxicology Nov, 2011 | Pubmed ID: 21950349
Systemic inflammation and prediction of chemotherapy outcomes in patients receiving docetaxel for advanced cancer.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer Oct, 2011 | Pubmed ID: 21986674
Clinicopathological correlates and prognostic significance of glutathione S-transferase Pi expression in 468 patients after potentially curative resection of node-positive colonic cancer.
Histopathology Dec, 2011 | Pubmed ID: 22175886
Src tyrosine kinase phosphorylation of nuclear receptor HNF4α correlates with isoform-specific loss of HNF4α in human colon cancer.
Proceedings of the National Academy of Sciences of the United States of America Feb, 2012 | Pubmed ID: 22308320